Method for preparing porous scaffold for tissue engineering

US9555164B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9555164-B2
Application numberUS-201514708996-A
CountryUS
Kind codeB2
Filing dateMay 11, 2015
Priority dateOct 11, 2007
Publication dateJan 31, 2017
Grant dateJan 31, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a method for preparing a porous scaffold for tissue engineering. It is another object of the present invention to provide a porous scaffold obtainable by the method as above described, and its use for tissue engineering, cell culture and cell delivery. The method of the invention comprise the steps consisting of a) preparing an alkaline aqueous solution comprising an amount of at least one polysaccharide and one cross-linking agent b) freezing the aqueous solution of step a) c) sublimating the frozen solution of step b) characterized in that step b) is performed before the cross-linking of the polysaccharide occurs in the solution of step a).

First claim

Opening claim text (preview).

The invention claimed is: 1. A porous scaffold obtainable by a method for preparing a porous scaffold consisting of the steps of a) preparing an alkaline aqueous solution comprising an amount of pullulan and dextran and one cross-linking agent; b) freezing the aqueous solution of step a); c) sublimating the frozen solution of step b); and wherein step b) is performed before the cross-linking of the pullulan and dextran and said cross linking occurs during the sublimation step c). 2. The porous scaffold according to claim 1 , wherein the cross-linking agent of the method for preparing said porous scaffold is selected from the group consisting of trisodium trimetaphosphate (STMP), phosphorus oxychloride (POCl3), epichlorohydrin, formaldehydes, water soluble carbodiimides, and glutaraldehydes. 3. The porous scaffold according to claim 1 , wherein the cross-linking agent of the method for preparing said porous scaffold is trisodium trimetaphosphate (STMP). 4. The porous scaffold according to claim 1 , wherein the aqueous solution of step a) of the method for preparing said porous scaffold is freeze-dried. 5. The porous scaffold according to claim 1 wherein the aqueous solution of step a) of the method for preparing said porous scaffold is freeze-dried under a pressure from 0.1 mBar to 6.5 mBar. 6. The porous scaffold according to claim 1 , wherein said scaffold is shaped. 7. The porous scaffold of claim 1 , wherein the size of the pores is comprised between 1 μm and 500 μm. 8. The porous scaffold according to claim 1 wherein the porosity is comprised between 4% and 50%. 9. The porous scaffold according to claim 1 for tissue engineering, 3D cell culture or cell delivery for therapeutic use. 10. A vascular substitute made with a scaffold of claim 1 . 11. Cartilage or bone implants made with a scaffold of claim claim 1 . 12. Method for evaluating the toxicity and/or pharmacology of a product comprising: culturing cells on the porous scaffold according to claim 1 ; contacting the cells with an amount of the product; identifying an effect on the cells following the contacting with the product; and determining the toxicity and/or pharmacology of the product based on the identified effect the product had on the cells. 13. A controlled release system of an active agent made with a scaffold as defined according to claim 1 .

Assignees

Inventors

Classifications

  • for artificial blood vessels (apparatus for applying cells on a blood vessel prosthesis A61F2/062) · CPC title

  • Acids · CPC title

  • by elimination of a liquid phase from a macromolecular composition or article, e.g. drying of coagulum · CPC title

  • characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells · CPC title

  • Pullulan, i.e. (alpha-1,4)(alpha-1,6)-D-glucan; Derivatives thereof · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9555164B2 cover?
The present invention relates to a method for preparing a porous scaffold for tissue engineering. It is another object of the present invention to provide a porous scaffold obtainable by the method as above described, and its use for tissue engineering, cell culture and cell delivery. The method of the invention comprise the steps consisting of a) preparing an alkaline aqueous solution comprisi…
Who is the assignee on this patent?
Inserm (Institut Nat De La Sante Et De La Rech Medicale), Univ Paris 7—Denis Diderot
What technology area does this patent fall under?
Primary CPC classification A61L27/56. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).